Related Experiment Videos
[Mechanical assistance of circulation. 42 cases]
D Loisance1, P H Deleuze, J P Mazzucotelli
1Service de Chirurgie thoracique et cardiovasculaire, UA CNRS Thérapeutives Substitutives du Coeur et des Vaisseaux, Créteil.
Presse Medicale (Paris, France : 1983)
|May 6, 1995
Summary
Mechanical circulatory support significantly improves survival for patients with cardiogenic shock. Early implantation of mechanical support devices is recommended to enhance patient outcomes.
Area of Science:
- Cardiology
- Medical Engineering
- Critical Care Medicine
Context:
- Mechanical circulatory support (MCS) is a vital therapeutic option for patients experiencing cardiogenic shock.
- It serves as a bridge to cardiac transplantation or facilitates weaning from mechanical ventilation.
- This study analyzes the initial 42 cases of MCS implementation.
Purpose:
- To evaluate the efficacy of mechanical circulatory support in patients with cardiogenic shock.
- To assess transplantability and hospital survival rates in this patient cohort.
- To identify factors influencing outcomes, including age and the learning curve associated with MCS.
Summary:
- The study included 42 patients: 31 with refractory cardiogenic shock awaiting transplantation and 11 requiring ventricular assist device support due to unweanability or intensive care unit shock.
- The overall success rate for MCS was 67%.
- Outcomes varied by etiology, with success rates of 25% in re-transplanted patients, 46% post-acute myocardial infarction, and 57% in cardiomyopathy.
Impact:
- Mechanical circulatory support demonstrates a positive impact on survival rates for patients with cardiogenic shock.
- The findings underscore the importance of timely MCS implantation for improved patient prognosis.
- This research contributes to the understanding of MCS application in severe heart failure management.